What causes hnpcc

Overview

Hereditary Nonpolyposis Colorectal Cancer (HNPCC), now more commonly referred to as Lynch syndrome, is the most frequent cause of hereditary colorectal cancer. It is an autosomal dominant genetic disorder characterized by an increased risk of developing cancers, particularly in the colon and rectum, but also in other organs. Unlike familial adenomatous polyposis (FAP), HNPCC is not characterized by the development of hundreds or thousands of precancerous polyps; instead, affected individuals develop fewer polyps, but these polyps have a higher propensity to become cancerous more quickly.

What is Lynch Syndrome?

Lynch syndrome is caused by inherited mutations in specific genes responsible for DNA mismatch repair (MMR). DNA is constantly being copied, and errors can occur during this process. The MMR system acts like a proofreader, identifying and correcting these errors. When MMR genes are mutated, this repair mechanism is faulty. Consequently, errors accumulate in the DNA, leading to genetic instability (microsatellite instability or MSI) and an increased likelihood of mutations occurring in other genes that control cell growth and division. This uncontrolled cell growth can ultimately lead to cancer.

Genetic Basis of HNPCC (Lynch Syndrome)

The primary cause of Lynch syndrome lies in mutations within the DNA mismatch repair (MMR) gene family. The most commonly affected genes include:

• MLH1 (MutL homolog 1)
• MSH2 (MutS homolog 2)
• MSH6 (MutS homolog 6)
• PMS2 (Postmeiotic segregation 2)

Mutations in another gene, EPCAM, can also contribute to Lynch syndrome by epigenetically silencing the MSH2 gene. When these genes are mutated, the MMR system cannot effectively repair DNA replication errors. These unrepaired errors, particularly in repetitive DNA sequences called microsatellites, lead to microsatellite instability (MSI). MSI is a hallmark of Lynch syndrome-associated cancers and is often used as a diagnostic marker.

Inheritance patterns for Lynch syndrome are autosomal dominant. This means that a person only needs to inherit one copy of the mutated gene from one parent to have the syndrome. If a parent has a mutation in one of these MMR genes, each of their children has a 50% chance of inheriting that mutation and thus developing Lynch syndrome.

Symptoms and Cancer Risks Associated with Lynch Syndrome

While the name HNPCC specifically refers to colorectal cancer, Lynch syndrome significantly increases the risk of several other cancers:

• Colorectal Cancer: This is the most common cancer associated with Lynch syndrome, with affected individuals having a lifetime risk of 50-80%, compared to about 4-5% in the general population. Cancers often develop at a younger age (before 50) and may occur in the right side of the colon.
• Endometrial Cancer (Uterine Cancer): Women with Lynch syndrome have a 25-60% lifetime risk of developing endometrial cancer, one of the highest risks among Lynch-associated cancers.
• Ovarian Cancer: The lifetime risk for ovarian cancer is estimated to be 9-12%.
• Gastric (Stomach) Cancer: The risk is elevated, though less than for colorectal or endometrial cancer.
• Other Cancers: Increased risks have also been observed for small intestine cancer, bile duct cancer, pancreatic cancer, urinary tract cancer, prostate cancer, and brain tumors (specifically glioblastoma).

It's important to note that not everyone with Lynch syndrome will develop cancer. However, the significantly increased risk necessitates proactive surveillance and early detection strategies.

Diagnosis and Management

Diagnosing Lynch syndrome typically involves a combination of methods:

• Family History: A detailed family history is crucial, looking for patterns of early-onset cancers, multiple affected relatives, and a history of colorectal or other Lynch-associated cancers.
• Tumor Testing: Testing the cancerous tumor for microsatellite instability (MSI) or loss of MMR protein expression (using immunohistochemistry) can indicate Lynch syndrome. If a tumor shows these characteristics, it suggests the patient may have Lynch syndrome, prompting further genetic testing.
• Genetic Testing: Blood or saliva tests can identify specific mutations in the MMR genes (MLH1, MSH2, MSH6, PMS2, EPCAM). This is the definitive way to confirm a diagnosis of Lynch syndrome.

Once diagnosed, management focuses on intensive cancer surveillance and risk-reducing strategies. This includes frequent colonoscopies (often every 1-2 years starting in adolescence or early adulthood), and for women, regular gynecological exams and ultrasounds. Risk-reducing surgeries, such as prophylactic hysterectomy and oophorectomy, may be considered for women at very high risk.

Prevention and Lifestyle

While the underlying cause of Lynch syndrome is genetic, lifestyle factors can play a role in overall cancer risk reduction for affected individuals. Maintaining a healthy diet rich in fruits, vegetables, and whole grains, limiting red and processed meats, engaging in regular physical activity, and avoiding tobacco and excessive alcohol consumption are generally recommended for everyone and may offer some benefit in reducing cancer risk.

Conclusion

Hereditary Nonpolyposis Colorectal Cancer (HNPCC), or Lynch syndrome, is a significant inherited cancer predisposition syndrome caused by mutations in DNA mismatch repair genes. Understanding its genetic basis, associated cancer risks, and the importance of early diagnosis through genetic testing and surveillance is critical for individuals and families affected by this condition to manage their health effectively and improve outcomes.